Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamine-induced hyperactivity.
D000315:Adrenalectomy; D000818:Animals; D004298:Dopamine / Q000502:physiology*; D006889:Hydroxycorticosteroids / Q000494:pharmacology; D006948:Hyperkinesis / Q000139:chemically induced / Q000503:physiopathology*; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D017397:Prefrontal Cortex / Q000187:drug effects / Q000502:physiology*; D011965:Receptors, Glucocorticoid / Q000037:antagonists & inhibitors / Q000502:physiology*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology*
D006889:Hydroxycorticosteroids; D011965:Receptors, Glucocorticoid; C085917:RU 43044; D008694:Methamphetamine; D004298:Dopamine